Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation

被引:49
作者
Marín, F
Corral, J
Roldán, V
González-Conejero, R
del Rey, ML
Sogorb, F
Lip, GYH
Vicente, V
机构
[1] Gen Hosp Univ Alicante, Serv Cardiol, Alicante 03010, Spain
[2] Hosp Morales Meseguer, Serv Hematol, Murcia, Spain
[3] Hosp San Vicente, Hematol Unit, Alicante, Spain
[4] Univ Birmingham, City Hosp, Dept Med, Haematosis Thrombosis & Vasc Biol Unit, Birmingham, W Midlands, England
关键词
atrial fibrillation; inflammation; tissue factor; polymorphism;
D O I
10.1016/j.yjmcc.2004.06.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atrial fibrillation (AF) has been shown to confer a prothrombotic or hypercoagulable state, which could be related to inflammation. Factor XIII (FXIII) catalyses the cross-linking of fibrin monomers, increasing clot resistance; specifically, a common polymorphism, Val34Leu, in the FXIII-A subunit gene has been associated with more rapid FXIII activation. We hypothesised a role for this polymorphism in the prothrombotic state and inflammation in AF, and tested this hypothesis by measurement of indices of coagulation (tissue factor (TF) and fibrinogen), inflammation (interleukin-6 (IL-6)) and platelet activation (soluble P selectin (sPsel)). Methods. We studied 90 stable outpatients (73 +/- 8 years) with persistent AF. The FXIII Val34Leu polymorphism was determined by polymerase chain reaction-allelic specific restriction assay (PCR-ASRA). Prevalence of Va134Leu polymorphism of patients was compared to 585 unrelated subjects from the same geographical area. Plasma fibrinogen (Clauss), TF, IL6 and sPsel (all ELISA) were quantified in patient group. Research indices were compared to 74 controls in sinus rhythm with similar clinical characteristics. Results. There were no statistical differences in FXIII polymorphism prevalence between AF patients and controls. Patients carrying the Leu34 allele had higher plasma levels of TF, IL6 and sPsel (all P < 0.05) compared to controls. Plasma IL6 and TF levels were significantly correlated (Spearman coefficient, r = 0.33, P < 0.01). On multivariate analysis, the Leu34 allele was independently associated with IL6 levels (P < 0.01), whereas TF levels were only associated with IL6 concentrations. However, sPsel and fibrinogen levels were not related to Leu34 allele. Conclusion. FXIII Va134Leu polymorphism was independently associated with IL6 levels in AF. The Leu34 allele may potentially influence the prothrombotic state in these patients by modulating the inflammatory state. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:699 / 704
页数:6
相关论文
共 39 条
[1]   Factor XIIIA Val34Leu polymorphism does not predict risk of coronary heart disease - The Atherosclerosis Risk in Communities (ARIC) study [J].
Aleksic, N ;
Ahn, C ;
Wang, YW ;
Juneja, H ;
Folsom, AR ;
Boerwinkle, E ;
Wu, KK .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (02) :348-352
[2]  
Alhenc-Gelas M, 2000, THROMB HAEMOSTASIS, V84, P1117
[3]   The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure [J].
Ariens, RAS ;
Philippou, H ;
Nagaswami, C ;
Weisel, JW ;
Lane, DA ;
Grant, PJ .
BLOOD, 2000, 96 (03) :988-995
[4]   Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms [J].
Ariëns, RAS ;
Lai, TS ;
Weisel, JW ;
Greenberg, CS ;
Grant, PJ .
BLOOD, 2002, 100 (03) :743-754
[5]   Inflammation as a risk factor for atrial fibrillation [J].
Aviles, RJ ;
Martin, DO ;
Apperson-Hansen, C ;
Houghtaling, PL ;
Rautaharju, P ;
Kronmal, RA ;
Tracy, RP ;
Van Wagoner, DR ;
Psaty, BM ;
Lauer, MS ;
Chung, MK .
CIRCULATION, 2003, 108 (24) :3006-3010
[6]  
Balogh I, 2000, BLOOD, V96, P2479
[7]   Genetic polymorphisms and coronary artery disease in the south of France [J].
Canavy, I ;
Henry, M ;
Morange, PE ;
Tiret, L ;
Poirier, O ;
Ebagosti, A ;
Bory, M ;
Juhan-Vague, I .
THROMBOSIS AND HAEMOSTASIS, 2000, 83 (02) :212-216
[8]   Association of the α-fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation [J].
Carter, AM ;
Catto, AJ ;
Grant, PJ .
CIRCULATION, 1999, 99 (18) :2423-2426
[9]   C-REACTIVE PROTEIN INDUCES HUMAN PERIPHERAL-BLOOD MONOCYTES TO SYNTHESIZE TISSUE FACTOR [J].
CERMAK, J ;
KEY, NS ;
BACH, RR ;
BALLA, J ;
JACOB, HS ;
VERCELLOTTI, GM .
BLOOD, 1993, 82 (02) :513-520
[10]   ISOLATION, CHARACTERIZATION, AND LOCATION OF A DONOR-ACCEPTOR UNIT FROM CROSS-LINKED FIBRIN [J].
CHEN, R ;
DOOLITTL.RF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1970, 66 (02) :472-&